Biopharmaceutical production in plants: problems, solutions and opportunities
- 30 November 2005
- journal article
- review article
- Published by Elsevier BV in Trends in Biotechnology
- Vol. 23 (11), 559-565
- https://doi.org/10.1016/j.tibtech.2005.09.003
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Recombinant anti‐hCG antibodies retained in the endoplasmic reticulum of transformed plants lack core‐xylose and core‐α(1,3)‐fucose residuesPlant Biotechnology Journal, 2004
- Generation of Arabidopsis thaliana plants with complex N‐glycans lacking β1,2‐linked xylose and core α1,3‐linked fucoseFEBS Letters, 2004
- Production and glycosylation of plant‐made pharmaceuticals: the antibodies as a challengePlant Biotechnology Journal, 2004
- In Vivo Conversion of a Glycan to Human Compatible Type by Transformed Tobacco CellsBiochemical and Biophysical Research Communications, 2001
- Antibody humanization: a case of the ‘Emperor’s new clothes’?Immunology Today, 2000
- Protein Recycling from the Golgi Apparatus to the Endoplasmic Reticulum in Plants and Its Minor Contribution to Calreticulin RetentionTHE PLANT CELL ONLINE, 2000
- Identification of the human Lewisa carbohydrate motif in a secretory peroxidase from a plant cell suspension culture (Vaccinium myrtillus L.)FEBS Letters, 1997
- Primary structure of the N-linked carbohydrate chains of Calreticulin from spinach leavesGlycoconjugate Journal, 1996
- Comparison of the immunogenicity of recombinant and pituitary human growth hormone in rhesus monkeys*1Fundamental and Applied Toxicology, 1991
- Cross-Reactions between Vegetable Foods, Pollen and Bee Venom Due to IgE Antibodies to a Ubiquitous Carbohydrate DeterminantInternational Archives of Allergy and Immunology, 1981